1248325

Apnar Pharma LP — FEI 3023702739

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chino, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)